ID   LBN_HUMAN               Reviewed;        1308 AA.
AC   Q86UK5; Q86YT3; Q86YT4; Q8NG49;
DT   07-NOV-2003, integrated into UniProtKB/Swiss-Prot.
DT   01-JUN-2003, sequence version 1.
DT   28-JUN-2023, entry version 150.
DE   RecName: Full=Limbin;
DE   AltName: Full=Ellis-van Creveld syndrome protein 2;
DE            Short=EVC2;
DE   Flags: Precursor;
GN   Name=EVC2; Synonyms=LBN;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2).
RC   TISSUE=Kidney;
RX   PubMed=12136126; DOI=10.1073/pnas.152337899;
RA   Takeda H., Takami M., Oguni T., Tsuji T., Yoneda K., Sato H., Ihara N.,
RA   Itoh T., Kata S.R., Mishina Y., Womack J.E., Moritomo Y., Sugimoto Y.,
RA   Kunieda T.;
RT   "Positional cloning of the gene LIMBIN responsible for bovine
RT   chondrodysplastic dwarfism.";
RL   Proc. Natl. Acad. Sci. U.S.A. 99:10549-10554(2002).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), AND VARIANT EVC ARG-283.
RX   PubMed=12571802; DOI=10.1086/368063;
RA   Ruiz-Perez V.L., Tompson S.W.J., Blair H.J., Espinoza-Valdez C.,
RA   Lapunzina P., Silva E.O., Hamel B.C.J., Gibbs J.L., Young I.D.,
RA   Wright M.J., Goodship J.A.;
RT   "Mutations in two nonhomologous genes in a head-to-head configuration cause
RT   Ellis-van Creveld syndrome.";
RL   Am. J. Hum. Genet. 72:728-732(2003).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 75-1308 (ISOFORMS 1 AND 3), TISSUE
RP   SPECIFICITY, AND VARIANT EVC TRP-950.
RX   PubMed=12468274; DOI=10.1016/s1096-7192(02)00178-6;
RA   Galdzicka M., Patnala S., Hirshman M.G., Cai J.-F., Nitowsky H.,
RA   Egeland J.A., Ginns E.I.;
RT   "A new gene, EVC2, is mutated in Ellis-van Creveld syndrome.";
RL   Mol. Genet. Metab. 77:291-295(2002).
RN   [4]
RP   INVOLVEMENT IN WEYERS ACROFACIAL DYSOSTOSIS.
RX   PubMed=16404586; DOI=10.1007/s00439-005-0129-2;
RA   Ye X., Song G., Fan M., Shi L., Jabs E.W., Huang S., Guo R., Bian Z.;
RT   "A novel heterozygous deletion in the EVC2 gene causes Weyers acrofacial
RT   dysostosis.";
RL   Hum. Genet. 119:199-205(2006).
RN   [5]
RP   VARIANTS [LARGE SCALE ANALYSIS] SER-630 AND VAL-994.
RX   PubMed=16959974; DOI=10.1126/science.1133427;
RA   Sjoeblom T., Jones S., Wood L.D., Parsons D.W., Lin J., Barber T.D.,
RA   Mandelker D., Leary R.J., Ptak J., Silliman N., Szabo S., Buckhaults P.,
RA   Farrell C., Meeh P., Markowitz S.D., Willis J., Dawson D., Willson J.K.V.,
RA   Gazdar A.F., Hartigan J., Wu L., Liu C., Parmigiani G., Park B.H.,
RA   Bachman K.E., Papadopoulos N., Vogelstein B., Kinzler K.W.,
RA   Velculescu V.E.;
RT   "The consensus coding sequences of human breast and colorectal cancers.";
RL   Science 314:268-274(2006).
CC   -!- FUNCTION: Component of the EvC complex that positively regulates
CC       ciliary Hedgehog (Hh) signaling. Plays a critical role in bone
CC       formation and skeletal development. May be involved in early embryonic
CC       morphogenesis. {ECO:0000250|UniProtKB:Q8K1G2}.
CC   -!- SUBUNIT: Component of the EvC complex composed of EFCAB7, IQCE, EVC2
CC       and EVC; built from two subcomplexes, EVC2:EVC and EFCAB7:IQCE.
CC       Interacts with EVC. Interacts (via N-terminal end) with EFCAB7.
CC       Interacts (via N-terminal end) with IQCE.
CC       {ECO:0000250|UniProtKB:Q8K1G2}.
CC   -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000250|UniProtKB:Q8K1G2};
CC       Single-pass type I membrane protein {ECO:0000250|UniProtKB:Q8K1G2}.
CC       Cytoplasm, cytoskeleton, cilium basal body
CC       {ECO:0000250|UniProtKB:Q8K1G2}. Cell projection, cilium
CC       {ECO:0000250|UniProtKB:Q8K1G2}. Cell projection, cilium membrane
CC       {ECO:0000250|UniProtKB:Q8K1G2}. Nucleus {ECO:0000250|UniProtKB:Q8K1G2}.
CC       Note=The EvC complex localizes at the base of cilia in the EvC zone of
CC       primary cilia in a EFCAB7-dependent manner.
CC       {ECO:0000250|UniProtKB:Q8K1G2}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=3;
CC         Comment=Additional isoforms seem to exist.;
CC       Name=1;
CC         IsoId=Q86UK5-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q86UK5-2; Sequence=VSP_008848;
CC       Name=3;
CC         IsoId=Q86UK5-3; Sequence=VSP_008849;
CC   -!- TISSUE SPECIFICITY: Found in the heart, placenta, lung, liver, skeletal
CC       muscle, kidney and pancreas. {ECO:0000269|PubMed:12468274}.
CC   -!- DISEASE: Ellis-van Creveld syndrome (EVC) [MIM:225500]: An autosomal
CC       recessive condition characterized by the clinical tetrad of
CC       chondrodystrophy, polydactyly, ectodermal dysplasia and cardiac
CC       anomalies. Patients manifest short-limb dwarfism, short ribs, postaxial
CC       polydactyly, and dysplastic nails and teeth. Congenital heart defects,
CC       most commonly an atrioventricular septal defect, are observed in 60% of
CC       affected individuals. {ECO:0000269|PubMed:12468274,
CC       ECO:0000269|PubMed:12571802}. Note=The disease is caused by variants
CC       affecting the gene represented in this entry.
CC   -!- DISEASE: Acrofacial dysostosis, Weyers type (WAD) [MIM:193530]: An
CC       autosomal dominant condition characterized by dysplastic nails,
CC       postaxial polydactyly, dental anomalies, short limbs, short stature and
CC       normal intelligence. The phenotype is milder than Ellis-van Creveld
CC       syndrome. {ECO:0000269|PubMed:16404586}. Note=The disease is caused by
CC       variants affecting the gene represented in this entry.
CC   -!- MISCELLANEOUS: [Isoform 3]: May be produced at very low levels due to a
CC       premature stop codon in the mRNA, leading to nonsense-mediated mRNA
CC       decay. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAN86577.1; Type=Erroneous initiation; Evidence={ECO:0000305};
CC       Sequence=AAN86578.1; Type=Erroneous initiation; Evidence={ECO:0000305};
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AB083067; BAC06590.1; -; mRNA.
DR   EMBL; AY185210; AAO22066.1; -; mRNA.
DR   EMBL; AY152402; AAN86577.1; ALT_INIT; mRNA.
DR   EMBL; AY152403; AAN86578.1; ALT_INIT; mRNA.
DR   CCDS; CCDS3382.2; -. [Q86UK5-1]
DR   CCDS; CCDS54718.1; -. [Q86UK5-2]
DR   RefSeq; NP_001159608.1; NM_001166136.1. [Q86UK5-2]
DR   RefSeq; NP_667338.3; NM_147127.4. [Q86UK5-1]
DR   RefSeq; XP_016863225.1; XM_017007736.1. [Q86UK5-2]
DR   RefSeq; XP_016863226.1; XM_017007737.1.
DR   AlphaFoldDB; Q86UK5; -.
DR   SMR; Q86UK5; -.
DR   BioGRID; 126340; 85.
DR   IntAct; Q86UK5; 84.
DR   MINT; Q86UK5; -.
DR   STRING; 9606.ENSP00000342144; -.
DR   GlyCosmos; Q86UK5; 1 site, No reported glycans.
DR   GlyGen; Q86UK5; 1 site.
DR   iPTMnet; Q86UK5; -.
DR   PhosphoSitePlus; Q86UK5; -.
DR   BioMuta; EVC2; -.
DR   DMDM; 38257827; -.
DR   EPD; Q86UK5; -.
DR   jPOST; Q86UK5; -.
DR   MassIVE; Q86UK5; -.
DR   PaxDb; Q86UK5; -.
DR   PeptideAtlas; Q86UK5; -.
DR   Antibodypedia; 22606; 140 antibodies from 30 providers.
DR   DNASU; 132884; -.
DR   Ensembl; ENST00000310917.6; ENSP00000311683.2; ENSG00000173040.13. [Q86UK5-2]
DR   Ensembl; ENST00000344408.10; ENSP00000342144.5; ENSG00000173040.13. [Q86UK5-1]
DR   GeneID; 132884; -.
DR   KEGG; hsa:132884; -.
DR   MANE-Select; ENST00000344408.10; ENSP00000342144.5; NM_147127.5; NP_667338.3.
DR   UCSC; uc003gij.4; human. [Q86UK5-1]
DR   AGR; HGNC:19747; -.
DR   CTD; 132884; -.
DR   DisGeNET; 132884; -.
DR   GeneCards; EVC2; -.
DR   HGNC; HGNC:19747; EVC2.
DR   HPA; ENSG00000173040; Low tissue specificity.
DR   MalaCards; EVC2; -.
DR   MIM; 193530; phenotype.
DR   MIM; 225500; phenotype.
DR   MIM; 607261; gene.
DR   neXtProt; NX_Q86UK5; -.
DR   OpenTargets; ENSG00000173040; -.
DR   Orphanet; 952; Acrofacial dysostosis, Weyers type.
DR   Orphanet; 289; Ellis Van Creveld syndrome.
DR   PharmGKB; PA134989044; -.
DR   VEuPathDB; HostDB:ENSG00000173040; -.
DR   eggNOG; ENOG502QQ5U; Eukaryota.
DR   GeneTree; ENSGT00940000154127; -.
DR   HOGENOM; CLU_007621_0_0_1; -.
DR   InParanoid; Q86UK5; -.
DR   OMA; IFFAQIK; -.
DR   OrthoDB; 4261679at2759; -.
DR   PhylomeDB; Q86UK5; -.
DR   TreeFam; TF331379; -.
DR   PathwayCommons; Q86UK5; -.
DR   Reactome; R-HSA-5632684; Hedgehog 'on' state.
DR   Reactome; R-HSA-5635838; Activation of SMO.
DR   SignaLink; Q86UK5; -.
DR   BioGRID-ORCS; 132884; 16 hits in 1148 CRISPR screens.
DR   ChiTaRS; EVC2; human.
DR   GenomeRNAi; 132884; -.
DR   Pharos; Q86UK5; Tbio.
DR   PRO; PR:Q86UK5; -.
DR   Proteomes; UP000005640; Chromosome 4.
DR   RNAct; Q86UK5; protein.
DR   Bgee; ENSG00000173040; Expressed in pancreatic ductal cell and 120 other tissues.
DR   ExpressionAtlas; Q86UK5; baseline and differential.
DR   Genevisible; Q86UK5; HS.
DR   GO; GO:0060170; C:ciliary membrane; IBA:GO_Central.
DR   GO; GO:0005929; C:cilium; ISS:UniProtKB.
DR   GO; GO:0005737; C:cytoplasm; IEA:UniProtKB-KW.
DR   GO; GO:0005856; C:cytoskeleton; IEA:UniProtKB-KW.
DR   GO; GO:0005634; C:nucleus; HDA:UniProtKB.
DR   GO; GO:0098797; C:plasma membrane protein complex; IBA:GO_Central.
DR   GO; GO:0007224; P:smoothened signaling pathway; ISS:UniProtKB.
DR   InterPro; IPR022076; Limbin.
DR   InterPro; IPR026501; Limbin/EVC.
DR   PANTHER; PTHR16795:SF14; LIMBIN; 1.
DR   PANTHER; PTHR16795; LIMBIN/ELLIS-VAN CREVELD PROTEIN; 1.
DR   Pfam; PF12297; EVC2_like; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; Cell membrane; Cell projection; Ciliopathy; Cilium;
KW   Coiled coil; Cytoplasm; Cytoskeleton; Disease variant; Dwarfism;
KW   Ectodermal dysplasia; Glycoprotein; Membrane; Nucleus; Reference proteome;
KW   Signal; Transmembrane; Transmembrane helix.
FT   SIGNAL          1..26
FT                   /evidence="ECO:0000255"
FT   CHAIN           27..1308
FT                   /note="Limbin"
FT                   /id="PRO_0000084363"
FT   TOPO_DOM        27..300
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        301..321
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        322..1308
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   REGION          36..76
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          784..816
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COILED          455..578
FT                   /evidence="ECO:0000255"
FT   COILED          636..800
FT                   /evidence="ECO:0000255"
FT   COILED          1001..1113
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        220
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   VAR_SEQ         1..80
FT                   /note="Missing (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:12136126"
FT                   /id="VSP_008848"
FT   VAR_SEQ         1220..1308
FT                   /note="SILKKTCLPLRERMIFSGKGSWPHLSLEPIGELAPVPIVGAETIDLLNTGEK
FT                   LFIFRNPKEPEISLHVPPRKKKNFLNAKKAMRALGMD -> RSGNQESFWQYLVGTPEI
FT                   GLIEWMSEK (in isoform 3)"
FT                   /evidence="ECO:0000303|PubMed:12468274"
FT                   /id="VSP_008849"
FT   VARIANT         230
FT                   /note="S -> G (in dbSNP:rs4689278)"
FT                   /id="VAR_051089"
FT   VARIANT         283
FT                   /note="I -> R (in EVC; dbSNP:rs137852926)"
FT                   /evidence="ECO:0000269|PubMed:12571802"
FT                   /id="VAR_017209"
FT   VARIANT         630
FT                   /note="A -> S (in a colorectal cancer sample; somatic
FT                   mutation)"
FT                   /evidence="ECO:0000269|PubMed:16959974"
FT                   /id="VAR_035933"
FT   VARIANT         699
FT                   /note="T -> A (in dbSNP:rs730469)"
FT                   /id="VAR_017210"
FT   VARIANT         950
FT                   /note="R -> W (in EVC; dbSNP:rs137852928)"
FT                   /evidence="ECO:0000269|PubMed:12468274"
FT                   /id="VAR_017211"
FT   VARIANT         994
FT                   /note="L -> V (in a colorectal cancer sample; somatic
FT                   mutation)"
FT                   /evidence="ECO:0000269|PubMed:16959974"
FT                   /id="VAR_035934"
FT   CONFLICT        1106
FT                   /note="L -> W (in Ref. 3; AAN86577)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   1308 AA;  147948 MW;  D1EC635F43495A9A CRC64;
     MDPSGSRGRP TWVLAGGLLA VALALGGRGC LGASSRPRWR PLGAQPPRDP QVAPRSGPGL
     RIPPGRSGAG PESSTQDLPC MIWPKVECCH FKTAVEAPLG MKLDKKMEVF IPLSTSAASS
     GPWAHSLFAF IPSWPKKNLF KRESPITHRL YGDISREVQG TSENGVIFQK CALVSGSSEA
     QTARIWLLVN NTKTTSSANL SELLLLDSIA GLTIWDSVGN RTSEGFQAFS KKFLQVGDAF
     AVSYAATLQA GDLGNGESLK LPAQLTFQSS SRNRTQLKVL FSITAEENVT VLPHHGLHAA
     GFFIAFLLSL VLTWAALFLM VRYQCLKGNM LTRHRVWQYE SKLEPLPFTS ADGVNEDLSL
     NDQMIDILSS EDPGSMLQAL EELEIATLNR ADADLEACRT QISKDIIALL LKNLTSSGHL
     SPQVERKMSA VFKKQFLLLE NEIQEEYDRK MVALTAECDL ETRKKMENQY QREMMAMEEA
     EELLKRAGER SAVECSNLLR TLHGLEQEHL RKSLALQQEE DFAKAHRQLA VFQRNELHSI
     FFTQIKSAIF KGELKPEAAK MLLQNYSKIQ ENVEELMDFF QASKRYHLSK RFGHREYLVQ
     NLQSSETRVQ GLLSTAAAQL THLIQKHERA GYLDEDQMEM LLERAQTEVF SIKQKLDNDL
     KQEKKKLHQK LITKRRRELL QKHREQRREQ ASVGEAFRTV EDAGQYLHQK RSLMEEHGAT
     LEELQERLDQ AALDDLRTLT LSLFEKATDE LRRLQNSAMT QELLKRGVPW LFLQQILEEH
     GKEMAARAEQ LEGEERDRDQ EGVQSVRQRL KDDAPEAVTE EQAELRRWEH LIFMKLCSSV
     FSLSEEELLR MRQEVHGCFA QMDRSLALPK IRARVLLQQF QTAWREAEFV KLDQAVAAPE
     LQQQSKVRKS RSKSKSKGEL LKKCIEDKIH LCEEQASEDL VEKVRGELLR ERVQRMEAQE
     GGFAQSLVAL QFQKASRVTE TLSAYTALLS IQDLLLEELS ASEMLTKSAC TQILESHSRE
     LQELERKLED QLVQQEAAQQ QQALASWQQW VADGPGILNE PGEVDSERQV STVLHQALSK
     SQTLLEQHQQ CLREEQQNSV VLEDLLENME ADTFATLCSQ ELRLASYLAR MAMVPGATLR
     RLLSVVLPTA SQPQLLALLD SATERHVDHA AESDGGAEQA DVGRRRKHQS WWQALDGKLR
     GDLISRGLEK MLWARKRKQS ILKKTCLPLR ERMIFSGKGS WPHLSLEPIG ELAPVPIVGA
     ETIDLLNTGE KLFIFRNPKE PEISLHVPPR KKKNFLNAKK AMRALGMD
//
